# Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients

> **NCT05411978** · PHASE4 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 900 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Idebenone+ placebo
- **DRUG:** Idebenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05411978
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-09
- **Primary completion:** 2024-06-20
- **Final completion:** 2024-06-20
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411978, "Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05411978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*